Holding(s) in Company

RNS Number : 5248J

Taptica International Ltd

05 December 2018

 

TR-1: Standard form for notification of major holdings

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)
1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:			Taptica International Ltd. (AIM: TAP)
1b. Please indicate if the issuer is a non-UK issuer  (please mark with an "X" if appropriate)
Non-UK issuer
2. Reason for the notification (please mark the appropriate box or boxes with an "X")
An acquisition or disposal of voting rights						X
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Details of person subject to the notification obligation
Name			Ibex Investors LLC
City and country of registered office (if applicable)			Denver, CO, USA
4. Full name of shareholder(s) (if different from 3.)
Name			Ibex Micorcap Fund LLLP Ibex Israel Fund LLLP
City and country of registered office (if applicable)			Dover, DE, USA Dover, DE, USA
5. Date on which the threshold was crossed or reached:			04/12/2018
6. Date on which issuer notified (DD/MM/YYYY):			05/12/2018
7. Total positions of person(s) subject to the notification obligation
	% of voting rights attached to shares (total of 8. A)	% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)		Total of both in % (8.A + 8.B)	Total number of voting rights of issuer
Resulting situation on the date on which threshold was crossed or reached	7.81%			7.81%	68,066,497
Position of previous notification (if applicable)	6.68%			6.68%

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached
A: Voting rights attached to shares
Class/type of shares ISIN code (if possible)		Number of voting rights					% of voting rights
		Direct (Art 9 of Directive 2004/109/EC) (DTR5.1)		Indirect (Art 10 of Directive 2004/109/EC) (DTR5.2.1)			Direct (Art 9 of Directive 2004/109/EC) (DTR5.1)		Indirect (Art 10 of Directive 2004/109/EC) (DTR5.2.1)
IL0011320343				5,317,500					7.81%
SUBTOTAL 8. A		5,317,500					7.81%
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))
Type of financial instrument		Expiration date	Exercise/ Conversion Period			Number of voting rights that may be acquired if the instrument is exercised/converted.			% of voting rights
			SUBTOTAL 8. B 1
B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
Type of financial instrument	Expiration date		Exercise/ Conversion Period		Physical or cash settlement			Number of voting rights	% of voting rights
					SUBTOTAL 8.B.2

9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an "X")
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer
Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) Ibex Investors LLC is the investment adviser of the investment funds listed below. The total disclosable hold-ing for Ibex Investors LLC is 5,317,500 shares (7.81% of voting rights).				x
Namexv	% of voting rights if it equals or is higher than the notifiable threshold	% of voting rights through financial instruments if it equals or is higher than the notifiable threshold	Total of both if it equals or is higher than the notifiable threshold
Ibex Israel Fund LLLP	7.56%
Ibex Microcap Fund LLLP	0.25%
10. In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional information
This disclosure has been calculated based on an issued share capital of 68,066,497.

Place of completion	Denver, CO, USA
Date of completion	05/12/2018

 

END

 

 

HOLFMMGZGKGGRZM